How are TKIs changing CNS care in EGFR/ALK-mutated NSCLC?
Our article highlights stronger BBB penetration, improved intracranial control, and the evolving role of SRS in brain mts.
https://t.co/y2n11TsumK
#NSCLC#BrainMetastases#EGFR#ALK#TKI#Oncology#LungCancer#SRS#CNS
It was a pleasure to have our abstract accepted at WCLC this year, and I truly appreciate the opportunity to continue contributing to meaningful progress in oncology. #WCLC#oncology#cancer
I am honored that my research was chosen as one of the top studies of the year at the European Lung Cancer Congress, which hosted over 5,000 participants, and was presented at one of the largest and most influential lung cancer conferences in the world.
@myESMO@LungCancerEu
We are thrilled to share our paper exploring patient outcomes and prognostic factors in elderly (aged 70 and over) with colorectal cancer, leveraging an extensive large real-world dataset of over 700 patients #Colon#Cancer#CancerResearch#CancerAwareness
https://t.co/6Vx4FvKlJr
Our real-world research investigates the efficacy and safety of combining neoadjuvant platinum-based chemotherapy with nivolumab in patients with NSCLC, with the goal of improving treatment outcomes (pCR) #neoadjuvant#immunotherapy#outcomes#lung#cancer https://t.co/nC8yGITpbJ
Because taking care of our oncologic patients requires a compassionate approach that addresses both their physical and emotional needs throughout their treatment journey, we had to check how could we help them with their emotional health🧐🧑🍳🤔 #Cancer#Health#support#healthcare
Cancer diagnosis and treatment can trigger significant psychological distress impacting patient outcomes and care. Therefore we aimed to examine the prevalence of and identify the risk factors for depression and anxiety among cancer patients @ShalataWalid
https://t.co/bEOD6NflWc
@Cancers_MDPI Because taking care of our oncologic patients requires a compassionate approach that addresses both their physical and emotional needs throughout their treatment journey, we had to check how could we help them with their emotional health.🧐🧑🍳🤔
I am proud that my research was selected as one of the top studies of the year from a conference with over 35K of participants and was presented at one of the largest and most important oncology conferences in the world 💊💉🧫🧬
@myESMO#ESMO2024
💪In the current research authors aimed to present and highlighting the effectiveness and safety of PD-1 inhibitors in the treatment of advanced cSCC of the skin among elderly and immunosuppressed patients✔️
👏by @shalatawalid et al.
📌Find out more here: https://t.co/St3xoeLDNe
Trt sequence of TKI vs chemo+/-IO in #BRAFV600E and #cMETexon14 mut #NSCLC is unclear. In this RWD collabor🇮🇱🇵🇱🇸🇮🇵🇹🇭🇷🇬🇷 in @MDPIOpenAccess we found:
➡️N=58 TKI vs other:
➡️ORR% 55.6 vs 21.7
➡️DCR% 66.7 vs 39.1
➡️TTD 11.6 vs 4.6 m
Always go for the 🎯!!
https://t.co/gr3jif0tsq
ברכות לד"ר וליד שלאעטה מהמרכז הרפואי סורוקה ולד"ר גל שטראוס מהמרכז הרפואי שיבא על קבלת פרס המתמחה המצטיין מטעם האגודה למלחמה בסרטן והאיגוד הישראלי לאונקולוגיה ורדיותרפיה. על המסירות, היחס החם לחולים ולמשפחות וחתירה למצוינות קלינית!
@soroka_mc@ShalataWalid
@GalStrauss
ברכות לד"ר וליד שלאעטה מהמרכז הרפואי סורוקה ולד"ר גל שטראוס מהמרכז הרפואי שיבא על קבלת פרס המתמחה המצטיין מטעם האגודה למלחמה בסרטן והאיגוד הישראלי לאונקולוגיה ורדיותרפיה. על המסירות, היחס החם לחולים ולמשפחות וחתירה למצוינות קלינית!
@soroka_mc@ShalataWalid
@GalStrauss
✨We are excited to share this #Review addressing cardiac toxicity associated with immune checkpoint inhibitors: a highly relevant problem in today’s modern treatment approaches✨
Find the full text here👉https://t.co/hV4Y9obxWP
👥by @ShalataWalid et al. @SorokaMed
✨We are excited to share this #Review addressing cardiac toxicity associated with immune checkpoint inhibitors: a highly relevant problem in today’s modern treatment approaches✨
Find the full text here👉https://t.co/hV4Y9obxWP
👥by @ShalataWalid et al. @SorokaMed